Fluzone High-Dose for 65 & Older

Fluzone High-Dose for 65 & Older

Background:

  • As people age, they become more susceptible to influenza-related complications due to immunosenescence, a natural and progressive weakening of the immune system over time.
  • As a result, seniors are less responsive to standard dose influenza vaccine
  • This is the rationale for the development of Fluzone High-Dose

 

What is Fluzone High-Dose:

  • Fluzone High-Dose contains 4 times the antigen of a standard dose influenza vaccine (60μg vs 15μg per dose)
  • It is indicated for patients 65 years of age and older
  • Fluzone High-Dose is the only vaccine demonstrated through a large randomized study to be more efficacious than standard dose vaccine in preventing influenza in adults 65 years and older
    • In a randomized, multicenter, double blind trail with 31,803 adults, it was shown that:
      • Fluzone High-Dose is 24.2% more efficacious than the regular flu vaccine against laboratory-confirmed influenza illness caused by any virus type or subtype in adults 65 years of age and older
  • Approximately 50 million doses have been distributed in the United States since 2009 with no serious adverse events

 

Package Information:

  • Does not contain gelatin, antibiotic, thimerosal or latex (natural rubber) and is considered safe for use in persons with latex allergies
    • Cost is $75/dose

 

Reference:

  • An Advisory Committee Statement (ACS)/National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2016-2017

 

 

 

June 2017

No comments found.

Your Comment